<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Toxicol.</journal-id>
<journal-title>Frontiers in Toxicology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Toxicol.</abbrev-journal-title>
<issn pub-type="epub">2673-3080</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1540468</article-id>
<article-id pub-id-type="doi">10.3389/ftox.2025.1540468</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Toxicology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Repetitive ozone exposure worsens features of muco-inflammatory disease in developed <italic>Scnn1b</italic>-Tg&#x2b; mice lungs</article-title>
<alt-title alt-title-type="left-running-head">Vo et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ftox.2025.1540468">10.3389/ftox.2025.1540468</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vo</surname>
<given-names>Thao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2934077/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patial</surname>
<given-names>Sonika</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/994336/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Saini</surname>
<given-names>Yogesh</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/625456/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Population Health and Pathobiology</institution>, <institution>College of Veterinary Medicine</institution>, <institution>North Carolina State University</institution>, <addr-line>Raleigh</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Division of translational Toxicology</institution>, <institution>National Institute of Environmental Health Sciences</institution>, <institution>Research Triangle Park</institution>, <addr-line>Durham</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/496099/overview">Jagjit S. Yadav</ext-link>, University of Cincinnati, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2341532/overview">Alane Blythe Dy</ext-link>, University of Arizona, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2177023/overview">Satish Madala</ext-link>, University of Cincinnati, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yogesh Saini, <email>ysaini@ncsu.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>05</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>7</volume>
<elocation-id>1540468</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>12</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Vo, Patial and Saini.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Vo, Patial and Saini</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Ambient exposure to ozone (O<sub>3</sub>), one of the six criteria pollutants, is associated with the exacerbation of respiratory symptoms in individuals with underlying lung diseases. Using <italic>Scnn1b</italic>-Tg&#x002B; (Tg&#x002B;) mice, a widely used model of muco-inflammatory lung disease, we have demonstrated that O<sub>3</sub> exposure during the early stages of postnatal lung development leads to exacerbated muco-inflammatory outcomes. However, it remains unclear whether O<sub>3</sub> affects the developed lungs differently than the underdeveloped lungs of Tg&#x002B; mice.</p>
</sec>
<sec>
<title>Methods</title>
<p>We exposed 3-week-old wild-type (WT) and Tg&#x002B; mice to either filtered air (FA) or 0.8 ppm O<sub>3</sub> for 3 weeks and examined the lung phenotypes 12-16 h post-last exposure.</p>
</sec>
<sec>
<title>Results</title>
<p>As compared to FA-exposed WT mice, O<sub>3</sub>-exposed WT mice showed increased bronchoalveolar lavage fluid (BALF) proteins, increased immune cells, increased inflammation, alveolar space enlargement, and tissue consolidation. As compared to FA-exposed WT mice, the FA-exposed Tg&#x002B; mice showed increased immune cells, elevated levels of inflammatory mediators, e.g., IL-5, G-CSF, MIP-2, KC, MIP-1&#x03B1;, MIP-1&#x03B2;, IP-10, TNF-&#x03B1;, and IL-17, increased inflammation, alveolar space enlargement, tissue consolidation. As compared to FA-exposed <italic>Scnn1b</italic>-Tg&#x002B; mice, O<sub>3</sub>-exposed Tg&#x002B; mice had increased total protein, total dsDNA, and phagocytosed lipid contents, in addition to exaggerated granulocytic recruitment, peripheral and bronchiolar inflammation, alveolar space enlargement, and tissue consolidation.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Together, our data using Tg&#x002B; mice with developed lungs exhibited several findings consistent with previous findings observed in Tg&#x002B; neonates. Interestingly, however, as opposed to the previous report in O<sub>3</sub>-exposed neonatal Tg&#x002B; mice, where the hallmark features of Tg&#x002B; airway disease, i.e., mucus obstruction and expression of major gel-forming mucins (MUC5B and MUC5AC) were found exacerbated by O<sub>3</sub> exposure, the FA- and O<sub>3</sub>-exposed Tg&#x002B; mice with developed lungs exhibited comparable responses. These differential responses suggest that the stage of lung development is an important factor in the modulation of epithelial remodeling following O<sub>3</sub> exposure.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ozone</kwd>
<kwd>mice</kwd>
<kwd>
<italic>Scnn1b</italic>-Tg&#x2b;</kwd>
<kwd>lung</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Immunotoxicology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>&#x201c;Ground level&#x201d; ozone (O<sub>3</sub>), one of the six criteria gases according to the National Ambient Air Quality Standards (NAAQS), is a global health risk (<xref ref-type="bibr" rid="B11">Cohen et al., 2017</xref>). Elevated ground level O<sub>3</sub> results in increased hospital admissions, which leads to substantial health and economic burdens (<xref ref-type="bibr" rid="B2">Awang et al., 2016</xref>; <xref ref-type="bibr" rid="B37">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="B39">Malig et al., 2016</xref>; <xref ref-type="bibr" rid="B55">Strickland et al., 2010</xref>; <xref ref-type="bibr" rid="B57">Tian et al., 2018</xref>). O<sub>3</sub> generation involves the reaction of ultraviolet sunlight with nitrogen oxides (NOx) and volatile organic compounds (VOCs), which can be found in commercial and industrial products (<xref ref-type="bibr" rid="B1">Allen et al., 1997</xref>; <xref ref-type="bibr" rid="B44">McDonald et al., 2018</xref>; <xref ref-type="bibr" rid="B51">Reinhart, 1993</xref>). As a gaseous pollutant, the respiratory tract is the primary target of O<sub>3</sub> toxicity (<xref ref-type="bibr" rid="B21">Goldstein, 1978</xref>; <xref ref-type="bibr" rid="B45">Mehlman and Borek, 1987</xref>; <xref ref-type="bibr" rid="B54">Stokinger, 1965</xref>). Ambient O<sub>3</sub> inhalation is linked to respiratory tract inflammation, resulting in coughs, chest tightness and reduced lung function (<xref ref-type="bibr" rid="B6">Bascom et al., 1996</xref>). According to the American Lung Association, O<sub>3</sub> affects children, elderly, and people with pre-existing lung comorbidities. Specifically, O<sub>3</sub> is known to exacerbate symptoms in patients with ongoing respiratory diseases such as asthma (<xref ref-type="bibr" rid="B30">Khatri et al., 2009</xref>), cystic fibrosis (CF) (<xref ref-type="bibr" rid="B15">Farhat et al., 2013</xref>; <xref ref-type="bibr" rid="B22">Goss et al., 2004</xref>) and chronic obstructive pulmonary disease (COPD) (<xref ref-type="bibr" rid="B56">Strosnider et al., 2019</xref>). However, the nature of interactions between O<sub>3</sub> and diseased lungs is not fully elucidated.</p>
<p>CF is a chronic and progressive hereditary disease that evolves from small airway obstruction with mucus plugging and air trapping, airway inflammation to chronic bacterial infection, bronchiectasis and ultimately death (<xref ref-type="bibr" rid="B23">Grasemann and Ratjen, 2023</xref>; <xref ref-type="bibr" rid="B53">Shteinberg et al., 2021</xref>). CF transmembrane conductance regulator (CFTR) is a chloride (Cl<sup>&#x2212;</sup>) channel and regulator of epithelial sodium (Na<sup>&#x2b;</sup>) ion channel (ENaC), which controls the optimal airway surface liquid layer (ASL) volume and effective mucociliary clearance in the airways (<xref ref-type="bibr" rid="B64">Mall, 2020</xref>). In CF, recessive mutations in CFTR gene result in the formation of non-functional CFTR ion channel, which fails to regulate Cl<sup>&#x2212;</sup> and bicarbonate (HCO<sub>3</sub>
<sup>&#x2212;</sup>) ions. The Na<sup>&#x2b;</sup>/Cl<sup>&#x2212;</sup> ionic imbalance creates osmotic gradient to draw ASL water into the epithelial cells, which depletes ASL volume and impairs mucociliary clearance (<xref ref-type="bibr" rid="B41">Mall et al., 2010</xref>). While CFTR mutated mice do not exhibit features of lung disease (<xref ref-type="bibr" rid="B34">Lewis et al., 2019</xref>), the <italic>Scnn1b-</italic>Tg&#x2b; mouse overexpresses sodium channel, non-voltage gated 1, beta subunit (<italic>Scnn1b)</italic> transgene in the club cells, which dictates increased ionic concentration of Na<sup>&#x2b;</sup> within the epithelial cells and establishes osmotic gradient to draw water from ASL (<xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>).</p>
<p>The <italic>Scnn1b-</italic>Tg&#x2b; mouse recapitulates the features of human CF lung disease such as mucus hyperconcentration, mucus obstruction, mucous cell metaplasia, susceptibility to bacterial infection and airway inflammation, making it a widely used model for CF (<xref ref-type="bibr" rid="B42">Mall et al., 2008</xref>; <xref ref-type="bibr" rid="B63">Zhou et al., 2011</xref>). Previously, the <italic>Scnn1b-</italic>Tg&#x2b; mouse has been studied in the context of environmental pollutants including cigarette smoke (<xref ref-type="bibr" rid="B14">Engle et al., 2019</xref>), secondhand smoke (<xref ref-type="bibr" rid="B35">Lewis et al., 2017</xref>), allergens (<xref ref-type="bibr" rid="B18">Fritzsching et al., 2017</xref>), and nanoparticles (<xref ref-type="bibr" rid="B19">Geiser et al., 2013</xref>; <xref ref-type="bibr" rid="B31">Kim et al., 2022</xref>). The effects of O<sub>3</sub> on muco-inflammatory responses in developing lungs of <italic>Scnn1b-</italic>Tg&#x2b; mice were previously reported (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). However, it remains unclear whether O<sub>3</sub> affects the developed lungs differently than the underdeveloped lungs of Tg&#x2b; mice. Accordingly, we hypothesized that post-weaning (PND 21 &#xb1; 3) repetitive O<sub>3</sub> exposure will exaggerate inflammatory responses and alter lung pathology in <italic>Scnn1b-</italic>Tg&#x2b; mice. Of note, mouse lung development is almost complete at the age of 3&#xa0;weeks (<xref ref-type="bibr" rid="B5">Bartman et al., 2020</xref>; <xref ref-type="bibr" rid="B50">Rackley and Stripp, 2012</xref>). Towards this, we repetitively exposed 3-week-old WT and <italic>Scnn1b-</italic>Tg&#x2b; (Tg&#x2b;) weanlings to filtered air (FA) or O<sub>3</sub> (0.8&#xa0;ppm) and examine the lung inflammatory responses and pathology after 3&#xa0;weeks of O<sub>3</sub> exposure by assessing relevant endpoints, i.e., immune cell recruitment, cytokine analyses, immunohistochemistry, gene expression analyses and pathological features. This study provides interesting insights into the effects of O<sub>3</sub> on muco-inflammatory responses in Tg&#x2b; mice with CF-like lung disease.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Mice breeding scheme and animal husbandry</title>
<p>
<italic>Scnn1b</italic>-Tg&#x2b; mice [<italic>Tg (Scgb1a1-Scnn1b)6608Bouc/J</italic>] on congenic C57BL/6J background were procured from Jackson Laboratory (Bar Harbor, ME). As previously reported, pups were genotyped for <italic>Scnn1b</italic> transgene using polymerase chain reaction (PCR) and were maintained in hot washed, individually ventilated cages on a 12&#xa0;h dark/light cycle at the Division of Laboratory Animal Medicine (DLAM) at Louisiana State University, Baton Rouge, LA (<xref ref-type="bibr" rid="B35">Lewis et al., 2017</xref>). Mice were supplied with food and water <italic>ad libitum</italic> except during filtered air (FA) or ozone (O<sub>3</sub>) exposure (4h/day). All animal procedures were performed under animal protocol approved by the Institutional Animal Care and Use Committee (IACUC) of Louisiana State University.</p>
</sec>
<sec id="s2-2">
<title>2.2 Ozone and filtered air exposure</title>
<p>
<italic>Scnn1b</italic>-Tg&#x2b; mice and wild-type (WT) littermates (PND 21 &#xb1; 3) were transferred to individual cages with perforated lids without access to food and water and were exposed to either FA or O<sub>3</sub> [0.822 &#xb1; 0.003 (SEM) ppm]. O<sub>3</sub> exposure was conducted as previously reported (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). O<sub>3</sub> was generated from the O<sub>3</sub> generator (TSE, Chesterfield, MO). O<sub>3</sub> concentration, along with chamber pressure, humidity and temperature were displayed as graphs and were monitored throughout the entire exposure period (3&#xa0;weeks, 5&#xa0;days/week, 4h/day). Mice are nocturnal and display higher physical activity in nightly conditions (<xref ref-type="bibr" rid="B25">Hawkins and Golledge, 2018</xref>). To simulate the real-life scenarios of higher activity phase in humans, mice were transferred to a dark chamber and were exposed to FA or O<sub>3</sub> during the night cycle.</p>
</sec>
<sec id="s2-3">
<title>2.3 Tissue harvesting and bronchoalveolar lavage fluid analyses</title>
<p>FA-exposed and O<sub>3</sub>-exposed WT and <italic>Scnn1b</italic>-Tg&#x2b; mice were anesthetized via intraperitoneal injection of 2,2,2-tribromoethanol (Millipore Sigma, Burlington, MA). Midline laparotomy was performed to expose and severe inferior vena cava for exsanguination and thoracotomy were performed to expose the lung and trachea. The left main stem bronchus was ligated with suture. The right lung lobes were lavaged with a body weight-adjusted volume of ice-cold Dulbecco&#x2019;s Phosphate Buffered Saline (DPBS) (Corning, Manassas, VA). Bronchoalveolar lavage fluid (BALF) was centrifuged at 500 &#xd7; g for 5&#xa0;min at 4&#xb0;C. Cell-free BALF supernatant was transferred to a new tube and stored at &#x2212;80&#xb0;C for total protein estimation, double-stranded (ds) DNA estimation, and cytokine analyses. Cell pellet was resuspended in 500&#xa0;&#xb5;L of fresh DPBS. Total cell counts were determined using a hemocytometer (Bright-Line, Horsham, PA). BALF cytospins were prepared and stained for differential cell counts (Modified Wright Giemsa stain Kit; Newcomer Supply, Middleton, WI). Unlavaged left lung lobe was stored in 10% neutral buffered formalin (NBF) for histopathological and immunohistochemical analyses, and lavaged right lung lobes were snap-frozen and stored at &#x2212;80&#xb0;C for gene expression analyses.</p>
</sec>
<sec id="s2-4">
<title>2.4 Oil-Red-O staining</title>
<p>BALF cytospin slides were prepared and stained for Oil-Red-O staining (Electron Microscopy Science, Hatfield, PA). Cytospin slides were fixed with 10% NBF for 1&#xa0;h and washed with distilled water twice, then washed with 60% isopropanol for 5&#xa0;min and dried completely at room temperature (RT). Air-dried cytospin slides were incubated with Oil-Red-O working solution (Oil-Red-O stock diluted with distilled water in 3:2 ratio) for 10&#xa0;min and washed with distilled water four times. Slides were counterstained with Harris hematoxylin (Millipore Sigma, Burlington, MA) for 1&#xa0;min, washed with tap water, and then submerged in 0.25% ammonia water for 1&#xa0;min. Slides were rinsed with tap water and mounted with glycerol jelly medium. Photomicrographs were captured using the ECLIPSE Ci-L microscope with DS-Fi2 camera attachment (Nikon, Melville, NY) for analysis.</p>
</sec>
<sec id="s2-5">
<title>2.5 Histopathology</title>
<p>Formalin-fixed left lungs were paraffin-embedded and sectioned at 5&#xa0;&#x3bc;m and processed for histopathological analyses. Hematoxylin and Eosin (H&#x26;E) staining (Millipore Sigma, Burlington, MA) was performed to examine the structural and morphological alternations in the lung architecture. Alcian blue/periodic acid-Schiff (AB/PAS) staining (Leica, Buffalo Grove, IL) was performed to access the airway mucus contents and mucous cell metaplasia (MCM) status. All the slides were graded by a board-certified anatomic pathologist in a blinded manner.</p>
</sec>
<sec id="s2-6">
<title>2.6 Bronchoalveolar lavage fluid analyses</title>
<p>Total protein contents in the cell-free BALF were determined by Bradford assay (Bio-Rad, Hercules, CA). Total dsDNA contents were measured using the Nanodrop 8000 spectrophotometer (Thermo Scientific, Waltham, MA). Cell-free supernatant was assayed with Luminex-XMAP-based assay (MCYTOMAG-70K) according to the manufacturer&#x2019;s instructions (EMD Millipore, Billerica, MA).</p>
</sec>
<sec id="s2-7">
<title>2.7 Immunohistochemistry</title>
<p>Immunohistochemical staining for Major Basic Protein (MBP), Lymphocyte antigen 6B.2 (Ly-6B.2), Resistin-like alpha (RETNLA), Matrix Metalloproteinase 12 (MMP12), Mucin 5B (MUC5B), Mucin 5AC (MUC5AC), was performed, as previously reported (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>), Briefly, formalin-fixed, paraffin-embedded lung sections were deparaffinized with Citrisolv (Decon Laboratories, King of Prussia, PA) and rehydrated to distilled water. Antigen retrieval was performed by incubating sections in Proteinase K (at 37&#xb0;C for 20&#xa0;min) for MBP and Ly-6B.2, or by boiling (at 95&#xb0;C&#x2013;100&#xb0;C for 30&#xa0;min) in citrate buffer for other markers, followed by cooling to RT. 3% hydrogen peroxide was used to quench endogenous peroxidases before blocking step and primary antibody incubation with rat monoclonal MBP primary antibody (MT-14.7.3; Mayo Clinic, Scottsdale, AZ), rat monoclonal Ly-6B.2 primary antibody (MCA771G; Clone 7/4, Bio-Rad, Hercules, CA), rabbit polyclonal MMP12 primary antibody (ab66157; Abcam, Cambridge, MA), rabbit polyclonal MUC5B primary antibody (UNC223; University of North Carolina, Chapel Hill, NC), rabbit polyclonal MUC5AC primary antibody (UNC294; University of North Carolina, Chapel Hill, NC), followed by diluted biotinylated secondary antibodies. The slides were then processed with VECTASTAIN Elite ABC HRP Kit (PK-6101; Vector Laboratories, Burlingame, CA), followed by chromogenic substrate conversion to insoluble colored precipitate using ImmPACT Nova RED HRP substrate Kit (SK-4800; Vector Laboratories, Burlingame, CA). Finally, the slides were counterstained with Gill&#x2019;s Hematoxylin-I, dehydrated in alcohol solution and mounted with VectaMount mounting media (H-5000; Vector Laboratories, Burlingame, CA). Fiji software (National Institute of Health) was used to determine the positively stained cells (<xref ref-type="bibr" rid="B52">Schindelin et al., 2012</xref>).</p>
</sec>
<sec id="s2-8">
<title>2.8 Gene expression</title>
<p>Gene expression analyses on mRNA harvested from right lungs were performed as previously described (<xref ref-type="bibr" rid="B36">Lewis et al., 2020b</xref>).</p>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analyses</title>
<p>One-way analysis of variance (ANOVA) followed by the Tukey&#x2019;s <italic>post hoc</italic> test for multiple comparisons was used to determine significant differences among groups. Student&#x2019;s t-test was used to determine significant differences between FA-exposed and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; groups. Outliers were identified and removed using Grubb&#x2019;s test. Individual data points in scatter plots represent individual animals. All data were expressed as mean &#xb1; standard error of the mean (SEM). <italic>P</italic>-value &#x3c; 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 8.0.1 (GraphPad Software, La Jolla, CA).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Ozone exposure increases total protein, double-stranded DNA, and lipid contents in the lung airspaces of <italic>Scnn1b</italic>-Tg&#x2b; (Tg&#x2b;) mice</title>
<p>To study the effects of ozone (O<sub>3</sub>) exposure in the lungs of wild-type (WT) and <italic>Scnn1b</italic>-Tg&#x2b; (Tg&#x2b;) mice, Tg&#x2b; and littermate WT weanlings (PND 21 &#xb1; 3) were exposed to filtered air (FA) or 0.8&#xa0;ppm O<sub>3</sub> for 3&#xa0;weeks (5&#xa0;days/week, 4h/day) during the night cycle and euthanized within 12&#x2013;16&#xa0;h of the final exposure. After necropsy, we assessed bronchoalveolar lavage fluid (BALF) proteins, BALF double-stranded (ds) DNA, BALF lipids, BALF immune cell counts, BALF cytokines, tissue granulocytic infiltration, tissue histopathology, and mucus contents (<xref ref-type="fig" rid="F1">Figure 1A</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Ozone exposure increases total protein, double-stranded DNA, and lipid contents in the lung airspaces of <italic>Scnn1b</italic>-Tg&#x2b; (Tg&#x2b;) mice<italic>.</italic> <bold>(A)</bold>. Experimental design of ozone (O<sub>3</sub>) exposure in wild-type (WT) and <italic>Scnn1b</italic>-Tg&#x2b; mice. <bold>(B)</bold> Total protein concentration (&#x3bc;g/mL) in the bronchoalveolar lavage fluid (BALF) from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. <bold>(C)</bold> Double-stranded (ds) DNA concentration (ng/&#x3bc;L) in the BALF from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent SEM, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. <bold>(D)</bold> Percent Oil-Red-O-stained macrophages in the BALF from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent SEM, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. <bold>(E)</bold> Representative photomicrographs of Oil-Red-O-stained cytospin made from BALF from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Red arrows depict lipid-laden macrophages. All photomicrographs were taken at same magnification.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g001.tif"/>
</fig>
<p>O<sub>3</sub> exposure has been reported to cause protein leakage into the airspaces, indicative of the disruption of the epithelial-endothelial barrier (<xref ref-type="bibr" rid="B12">Currie et al., 1998</xref>; <xref ref-type="bibr" rid="B46">Michaudel et al., 2018</xref>; <xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). Moreover, extracellular double-stranded (ds) DNA is an indicator of epithelial injury and inflammation (<xref ref-type="bibr" rid="B32">Kirchner et al., 1996</xref>; <xref ref-type="bibr" rid="B29">Joyner et al., 2013</xref>). To assess the levels of protein and dsDNA in the lung airspaces of WT and Tg&#x2b; mice, we assayed the total protein and dsDNA contents in the cell-free BALF supernatant from FA- and O<sub>3</sub>-exposed WT and Tg&#x2b; groups. The total protein contents were increased in the BALF from O<sub>3</sub>-exposed WT versus FA-exposed WT mice, but the differences were not statistically significant (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The total protein contents were significantly increased in the BALF from O<sub>3</sub>-exposed Tg&#x2b; versus other three groups (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The BALF dsDNA contents were comparable in the O<sub>3</sub>-exposed WT versus FA-exposed WT mice. As compared to the remaining three groups, the O<sub>3</sub>-exposed Tg&#x2b; mice exhibited significant increase in BALF dsDNA contents (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<p>O<sub>3</sub> is known to cause lipid peroxidation (<xref ref-type="bibr" rid="B7">Chen et al., 2007</xref>) and alveolar macrophages are involved in the phagocytic clearance of these lipids (<xref ref-type="bibr" rid="B13">Dahl et al., 2007</xref>). Since the Tg&#x2b; mice possess hyper-concentrated airway surface liquid (<xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>), we speculated that the levels of oxidized lipids will be elevated in the airspaces of O<sub>3</sub>-exposed Tg&#x2b; mice. Accordingly, we assessed the levels of phagocytosed lipids in alveolar macrophages from the FA- and O<sub>3</sub>-exposed WT and Tg&#x2b; mice. While the FA-exposed WT mice were devoid of Oil-Red-O-stained macrophages, &#x223c;10% macrophages in the FA-exposed Tg&#x2b; mice were stained positively with Oil-Red-O staining. While O<sub>3</sub>-exposed WT showed &#x223c;2% macrophages with Oil-Red-O staining, &#x223c;21% of the alveolar macrophages from O<sub>3</sub>-exposed Tg&#x2b; mice were positively stained with Oil-Red-O staining (<xref ref-type="fig" rid="F1">Figures 1D,E</xref>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Ozone exposure disrupts the immune cell composition and alters the level of inflammatory mediators in the lung airspaces of WT and <italic>Scnn1b</italic>-Tg&#x2b; mice</title>
<p>To examine the effect of repetitive O<sub>3</sub> exposure on the immune cell profiles in the lung airspaces, we performed immune cell analyses on the BALF from FA- or O<sub>3</sub>-exposed WT and Tg&#x2b; mice. As compared to the FA-exposed WT mice, the O<sub>3</sub>-exposed WT mice exhibited a significant increase of total cell counts in the BALF, which was attributable to the significant increase in macrophage counts (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;D</xref>). While the neutrophils and eosinophils were identified in the BALF from O<sub>3</sub>-exposed WT versus FA-exposed WT mice, the differences were not statistically significant (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;D</xref>). As compared to the FA-exposed Tg&#x2b; mice, the O<sub>3</sub>-exposed Tg&#x2b; mice exhibited a significant increase of total cell counts in the BALF, which was attributable to the significant increase in neutrophil and eosinophil counts (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;D</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Ozone exposure disrupts the immune cell composition and alters the level of inflammatory mediators in the lung airspaces of WT and <italic>Scnn1b</italic>-Tg&#x2b; mice. <bold>(A)</bold> Total cell counts (cells x10<sup>3</sup>/lung) from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. <bold>(B, C)</bold> Differential cell counts in stacked bar graphs [Macrophage (red), Neutrophils (blue), Eosinophils (green), Lymphocytes (purple)]. Error bars represent SEM, &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. <bold>(D)</bold> Representative photomicrographs of Wright-Giemsa-stained BALF cytospin from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice [Macrophages (red arrows), Neutrophils (blue arrows), Eosinophils (green arrows), Lymphocytes (purple arrows)]. All photomicrographs were taken at same magnification. <bold>(E)</bold> Representative photomicrographs of Lymphocyte antigen 6B.2 (Ly-6B.2) (upper panels) and Major Basic Protein (MBP) (bottom panels)-stained lung sections from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Blue arrows depict neutrophils positively stained for Ly-6B.2; green arrows depict eosinophils positively stained for MBP. All photomicrographs were taken at same magnification. Fiji quantification of <bold>(F)</bold> Ly-6B.2- and <bold>(G)</bold> MBP-stained cells per unit area analyzed in tissue sections from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Error bars represent SEM, &#x2a;<italic>p</italic> &#x3c; 0.05 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test. Cytokine levels (pg/ml; picogram per milliliter) of <bold>(H)</bold> monocyte chemoattractant protein-1 (MCP-1) and <bold>(I)</bold> interleukin-5 (IL-5) in BALF from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Error bars represent SEM, &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g002.tif"/>
</fig>
<p>To further assess the presence of inflammatory cells in the lung tissues, immunohistochemical analyses were performed for neutrophils, i.e., Lymphocyte antigen 6B.2 (Ly-6B.2) and eosinophils, i.e., Major Basic Protein (MBP) (<xref ref-type="fig" rid="F2">Figures 2E&#x2013;G</xref>). Consistent with the increased BALF granulocytic counts in O<sub>3</sub>-exposed Tg&#x2b; mice, the tissue staining of Ly-6B.2 and MBP was markedly increased in O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F2">Figures 2E&#x2013;G</xref>). These data suggest that O<sub>3</sub> exposure exaggerates the recruitment of immune cells to the Tg&#x2b; mice lungs.</p>
<p>To determine the correlations between the immune cell infiltrations and the levels of immune cell chemoattractants in the airspaces of O<sub>3</sub>-exposed WT and Tg&#x2b; mice, we assayed the levels of chemoattractants in the cell-free BALF of FA- and O<sub>3</sub>-exposed WT and Tg&#x2b; mice. The levels of monocyte chemoattractant protein-1 (MCP-1/CCL2) and interleukin-5 (IL-5) were comparable between the BALF of O<sub>3</sub>-exposed versus FA-exposed WT mice (<xref ref-type="fig" rid="F2">Figures 2H,I</xref>). The increase in neutrophil and eosinophil counts in the BALF and lung tissue was associated with the significantly increased levels of monocyte chemoattractant protein-1 (MCP-1/CCL2) and interleukin-5 (IL-5) in the BALF of O<sub>3</sub>-exposed versus FA-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F2">Figures 2H,I</xref>). Additional data for other inflammatory mediators are included in <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>. The BALF levels of granulocyte-colony stimulating factor (G-CSF), keratinocyte chemoattractant (KC/CXCL1), and macrophage inflammatory protein 2 (MIP-2/CXCL2), responsible for neutrophils production, recruitment, and activation, were comparable in FA- and O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figures S1A&#x2013;C</xref>). While the levels of macrophage inflammatory protein 1-alpha (MIP-1&#x3b1;/CCL3), a chemoattractant for innate immune cells including macrophages, eosinophils, neutrophils, and lymphocytes, were decreased in O<sub>3</sub>-exposed Tg&#x2b; mice versus FA-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figure S1D</xref>), the levels of macrophage inflammatory protein 1-beta (MIP-1&#x3b2;/CCL4) were comparable between FA- and O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figure S1E</xref>). On the other hand, the levels of pro-inflammatory cytokines, i.e., interleukin-1 alpha (IL-1&#x3b1;), and tumor necrosis factor alpha (TNF-&#x3b1;), were decreased in O<sub>3</sub>-exposed Tg&#x2b; mice versus FA-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figures S1F, G</xref>). The levels of interleukin-6 (IL-6), C-X-C motif chemokine 10 (CXCL10/IP-10), and interleukin-17 (IL-17), consistently found in chronic and sub-chronic O<sub>3</sub>-exposed airspaces, trended higher in O<sub>3</sub>-exposed Tg&#x2b; mice as compared to FA-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figures S1H&#x2013;J</xref>). Of note, the levels of anti-inflammatory cytokines, i.e., interleukin-9 (IL-9), and interleukin-10 (IL-10) were significantly decreased in O<sub>3</sub>-exposed Tg&#x2b; mice as compared to FA-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figures S1K, L</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Ozone exposure exacerbates lung pathology in WT and <italic>Scnn1b</italic>-Tg&#x2b; mice</title>
<p>The alterations in lung architecture and pathology associated with the inflammatory changes of <italic>Scnn1b</italic>-Tg&#x2b; mice following O<sub>3</sub> exposure were evaluated. As compared with the FA-exposed WT mice, the O<sub>3</sub>-exposed WT mice displayed perivascular and peribronchiolar inflammation, alveolar space enlargement, and consolidation around alveolar septa (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;E</xref>). As previously reported (<xref ref-type="bibr" rid="B35">Lewis et al., 2017</xref>; <xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>), the FA-exposed Tg&#x2b; mice had significant perivascular and peribronchiolar inflammation, alveolar space enlargement, and consolidation (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;E</xref>). As compared with FA-exposed Tg&#x2b; mice, the O<sub>3</sub>-exposed Tg&#x2b; mice exhibited significantly increased perivascular and peribronchiolar inflammation, alveolar space enlargement, and septal thickening/consolidation (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;E</xref>). Notably, the number of lymphoid follicles per section were not different between FA- and O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F3">Figures 3A&#x2013;E</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Ozone exposure exacerbates lung pathology in WT and <italic>Scnn1b</italic>-Tg&#x2b; mice. <bold>(A)</bold> Representative photomicrographs of Hematoxylin and Eosin (H&#x26;E)-stained lung sections from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Double-headed arrows (all with similar dimensions) depict linear alveolar space width; black arrows depict immune cell infiltration in peribronchiolar spaces. All photomicrographs were taken at same magnification. Semiquantitative histopathological scores for <bold>(B)</bold> inflammation, <bold>(C)</bold> alveolar space enlargement, <bold>(D)</bold> lymphoid follicles per section, and <bold>(E)</bold> consolidation in FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Ozone exposure increases MMP12 production in <italic>Scnn1b</italic>-Tg&#x2b; mice</title>
<p>MMP12 is a macrophage metalloprotease responsible for the proteolytic attack on the alveolar wall matrix, resulting in emphysema (<xref ref-type="bibr" rid="B16">Finlay et al., 1997</xref>; <xref ref-type="bibr" rid="B26">Hendrix and Kheradmand, 2017</xref>). MMP12 is critical in the formation of emphysema in <italic>Scnn1b</italic>-Tg&#x2b; model (<xref ref-type="bibr" rid="B59">Trojanek et al., 2014</xref>). To determine whether the enhanced emphysematous responses in the O<sub>3</sub>-exposed Tg&#x2b; mice are caused by the upregulated expression of MMP12, we assessed MMP12 protein contents and <italic>Mmp12</italic> mRNA levels in the lungs of FA- and O<sub>3</sub>-exposed mice. MMP12 protein contents and <italic>Mmp12</italic> mRNA levels were comparable between the lungs of FA- and O<sub>3</sub>-exposed WT mice (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). The O<sub>3</sub>-exposed Tg&#x2b; mice had significantly increased MMP12&#x2b; cell counts versus FA-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). Furthermore, the MMP12&#x2b; cells staining intensity were enhanced in O<sub>3</sub>-exposed Tg&#x2b; mice as compared to FA-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). These data suggest that O<sub>3</sub> exposure may enhance MMP12 activity in <italic>Scnn1b</italic>-Tg&#x2b; mice and result in exaggerated alveolar space enlargement (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). Consistent with MMP12 immunostaining, the <italic>Mmp12</italic> mRNA levels were increased in O<sub>3</sub>-exposed Tg&#x2b; mice versus FA-exposed Tg&#x2b; mice, but the differences were not statistically significant (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Ozone exposure increases MMP12 production in <italic>Scnn1b</italic>-Tg&#x2b; mice. <bold>(A)</bold> Representative photomicrographs of MMP12-stained lung sections from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Red arrows depict cells positively stained for MMP12. All photomicrographs were taken at same magnification. <bold>(B)</bold> Absolute quantification of <italic>Mmp12</italic> mRNA in FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison <italic>post hoc</italic> test.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 Ozone does not exacerbate mucus obstruction and mucous cell metaplasia in <italic>Scnn1b</italic>-Tg&#x2b; mice</title>
<p>Airway mucus obstruction is a hallmark feature of human CF and CF-like lung disease in <italic>Scnn1b</italic>-Tg&#x2b; mouse model (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>; <xref ref-type="bibr" rid="B33">Lewis et al., 2020a</xref>; <xref ref-type="bibr" rid="B36">2020b</xref>; <xref ref-type="bibr" rid="B35">2017</xref>; <xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>; <xref ref-type="bibr" rid="B43">Mao et al., 2022</xref>). To examine the effects of O<sub>3</sub> on the progression of mucus obstruction, we used Alcian Blue-PAS (AB-PAS) staining to access the mucous cell metaplasia (MCM) and mucus obstruction status in the airways of FA- and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; mice. The MCM and mucus obstruction levels were comparable in O<sub>3</sub>-exposed as compared to FA-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Ozone does not exacerbate mucus obstruction and mucous cell metaplasia in <italic>Scnn1b</italic>-Tg&#x2b; mice <bold>(A)</bold> Representative photomicrograph of alcian blue/periodic acid-Schiff (AB/PAS)-stained lung sections from FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. All photomicrographs were taken at same magnification. <bold>(B)</bold> Quantification of AB/PAS-stained cells per unit area analyzed in tissue sections from FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM) using Student&#x2019;s t-test. <bold>(C)</bold> Semiquantitative histopathological scores for mucus obstruction in FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent SEM, using Student&#x2019;s t-test. <bold>(D)</bold> Representative photomicrograph of MUC5B-stained lung sections from FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. All photomicrographs were taken at same magnification. <bold>(E)</bold> Quantification of MUC5B (left panel), and MUC5AC (right panel)-stained cells per unit area analyzed in tissue sections from FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent SEM using Student&#x2019;s t-test. <bold>(F)</bold> Representative photomicrograph of MUC5AC-stained lung sections from FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. <bold>(G)</bold> Absolute quantification of <italic>Muc5b</italic> (left panel) and <italic>Muc5ac</italic> (right panel) mRNA in FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent SEM using Student&#x2019;s t-test.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g005.tif"/>
</fig>
<p>MUC5B and MUC5AC are the most common gel forming mucins in the airways of human CF and CF-like lung disease mouse model (<xref ref-type="bibr" rid="B38">Livraghi-Butrico et al., 2017</xref>). Therefore, to examine the role of O<sub>3</sub> in the expression of these mucin-forming proteins, we performed immunolocalization of MUC5B and MUC5AC in the lung sections of FA- and O<sub>3</sub>-exposed Tg&#x2b; mice. The immunostaining MUC5B and MUC5AC was comparable between in O<sub>3</sub>-exposed and FA-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F5">Figures 5D,E</xref>). Consistent with the immunohistochemistry data, gene expression data of mucin genes, i. e., <italic>Muc5ac</italic> and <italic>Muc5b</italic> showed no difference between FA- and O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="fig" rid="F5">Figures 5F,G</xref>). Of note O<sub>3</sub> exposure induces a significant upregulation of Resistin-like alpha (RETNLA), a M2 macrophage protein marker, in the airway epithelial cells and macrophages of adult mice (<xref ref-type="bibr" rid="B9">Choudhary et al., 2021b</xref>). Consistently, in the current study, we observed RETNLA-expressing cells were significantly elevated in the lung sections of O<sub>3</sub>-exposed versus FA-exposed Tg&#x2b; mice (<xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>The initiation of ozone (O<sub>3</sub>)-induced airway injury involves the ozonation of proteins, lipids, and other metabolite contents in the airway surface liquid (ASL) (<xref ref-type="bibr" rid="B49">Patial and Saini, 2020</xref>). In human cystic fibrosis (CF) lung disease, the ASL dehydration causes the hyperconcentration of various solids that are present in the airways, which results in various outcomes including compromised mucociliary function, mucin hypersecretion, mucus obstruction, and airway inflammation (<xref ref-type="bibr" rid="B34">Lewis et al., 2019</xref>). The <italic>Scnn1b</italic>-Tg&#x2b; (Tg&#x2b;) mice, due to ion channel dysfunction-mediated ASL dehydration, manifest most of the CF lung disease features (<xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>). Our previous reports demonstrated remarkable similarities between the lung disturbances caused due to the ASL dehydration in Tg&#x2b; mice and sub-chronic O<sub>3</sub>-induced lung disease in C57BL/6J mice (<xref ref-type="bibr" rid="B8">Choudhary et al., 2021a</xref>; <xref ref-type="bibr" rid="B9">2021b</xref>). These similarities led us to test our hypothesis that the superimposition of O<sub>3</sub> exposure on Tg&#x2b; muco-inflammatory disease will result in the worsening of Tg&#x2b; lung disease in the developing postnatal lung (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). Our investigation revealed interesting findings on how the O<sub>3</sub> exposure impacts the pathological features of Tg&#x2b; lung disease (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). However, the effects of O<sub>3</sub> exposure in the developed lungs of <italic>Scnn1b</italic>-Tg&#x2b; mice remained untested.</p>
<p>In this study, we focused our investigation into the interactions between O<sub>3</sub> exposure and muco-inflammatory airway disease during the postweaning period, when the lung development is almost complete (<xref ref-type="bibr" rid="B5">Bartman et al., 2020</xref>; <xref ref-type="bibr" rid="B50">Rackley and Stripp, 2012</xref>). O<sub>3</sub> is a highly reactive but less water-soluble gas (<xref ref-type="bibr" rid="B20">Gerrity et al., 1995</xref>). Before reaching lung epithelium, O<sub>3</sub> molecules interact with the constituents in the ASL, such as proteins, lipids, antioxidants, and immune cells (<xref ref-type="bibr" rid="B49">Patial and Saini, 2020</xref>). Therefore, the cellular damage caused by O<sub>3</sub> is less likely a direct result of its interaction with epithelial cells, and is more likely mediated by the action of various ozonation products (<xref ref-type="bibr" rid="B49">Patial and Saini, 2020</xref>). <italic>Scnn1b</italic>-Tg&#x2b; mice exhibit increased concentration of percent solids in the ASL layer, which are likely the immediate targets of ozonation. Therefore, we speculated that, as compared with the WT mice, the <italic>Scnn1b</italic>-Tg&#x2b; mice would be exposed to higher levels of ozonated ASL contents and, consequently, display amplified inflammatory responses.</p>
<p>In the current study, we observed a significant increase in total protein and dsDNA contents in O<sub>3</sub>-exposed Tg&#x2b; mice as compared to FA-exposed Tg&#x2b; mice. Repetitive O<sub>3</sub> exposure has been reported to be associated with epithelial cell death (<xref ref-type="bibr" rid="B58">Triantaphyllopoulos et al., 2011</xref>). It is likely that O<sub>3</sub> causes extensive cellular necrosis to the airway epithelium of <italic>Scnn1b</italic>-Tg&#x2b; mice, resulting in the marked increase of dsDNA and protein contents. The observed elevated total protein contents in O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; mice can also be attributed to other factors, e.g., disruption of the integrity of the gas exchange barrier, resulting in the leakage of proteins into the alveolar airspaces (<xref ref-type="bibr" rid="B12">Currie et al., 1998</xref>; <xref ref-type="bibr" rid="B46">Michaudel et al., 2018</xref>), excessive release of protein products from recruited cells, i.e., eosinophil granule proteins (<xref ref-type="bibr" rid="B28">Jacobsen et al., 2017</xref>) and the formation of neutrophil extracellular traps (NETs) (<xref ref-type="bibr" rid="B61">Xu et al., 2024</xref>).</p>
<p>Alveolar space enlargement is a consistent feature in <italic>Scnn1b</italic>-Tg&#x2b; mouse model (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>; <xref ref-type="bibr" rid="B42">Mall et al., 2008</xref>), which is associated with the release of MMP12, a matrix metalloproteinase, by activated airway macrophages (<xref ref-type="bibr" rid="B59">Trojanek et al., 2014</xref>). MMP12 causes alveolar wall destruction, leading to alveolar space enlargement (<xref ref-type="bibr" rid="B16">Finlay et al., 1997</xref>; <xref ref-type="bibr" rid="B26">Hendrix and Kheradmand, 2017</xref>). MMP12 is expressed in alveolar macrophages of smokers with chronic obstructive pulmonary disease (COPD), but is rarely detected in healthy macrophages (<xref ref-type="bibr" rid="B3">Babusyte et al., 2007</xref>). In the current study, we observed MMP12-expressing cells in the lung tissue from FA-exposed Tg&#x2b; mice. MMP12 has been reported to be an important mediator in the pathogenesis of both acute and chronic lung injury (<xref ref-type="bibr" rid="B24">Hautamaki et al., 1997</xref>; <xref ref-type="bibr" rid="B47">N&#xe9;nan et al., 2007</xref>; <xref ref-type="bibr" rid="B60">Warner et al., 2001</xref>). Disruption of <italic>Mmp12</italic> gene resulted in reduced total BAL protein, reduced neutrophil infiltration into the lung airspaces and reduced lung injury following an immune complex-induced acute lung injury (<xref ref-type="bibr" rid="B60">Warner et al., 2001</xref>). Moreover, studies using MMP12 knockout mice have demonstrated that MMP12 is linked to the development of alveolar space enlargement following chronic cigarette smoke exposure (<xref ref-type="bibr" rid="B24">Hautamaki et al., 1997</xref>). Additionally, a single instillation of recombinant human MMP12 (rhMMP12) was used to test the direct effect of MMP12 in the development of the inflammatory process in mouse airways. Accordingly, rhMMP12 induced an acute recruitment of neutrophils that was associated with the increased of pro-inflammatory mediators (<xref ref-type="bibr" rid="B47">N&#xe9;nan et al., 2007</xref>). In the current study, the O<sub>3</sub> exposure of <italic>Scnn1b</italic>-Tg&#x2b; lung disease resulted in alveolar space enlargement, which is likely an outcome of enhanced macrophage and neutrophil recruitment, and an increase in MMP12-expressing macrophages.</p>
<p>Longitudinal BAL <italic>Scnn1b</italic>-Tg&#x2b; studies demonstrated that airway inflammation is characterized by the early influx of neutrophils (&#x223c;PND5), succeeded by the influx of macrophages and eosinophils (&#x223c;PND14). These leucocyte influxes are waned when <italic>Scnn1b</italic>-Tg&#x2b; mice reach juvenile stage (<xref ref-type="bibr" rid="B63">Zhou et al., 2011</xref>). This is consistent with our findings, where FA-exposed Tg&#x2b; mice did not exhibit extensive neutrophils and eosinophils recruitment that were observed in their neonatal counterparts (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). These differences in granulocytic infiltration suggest that developed Tg&#x2b; lungs are less sensitive to O<sub>3</sub>-induced granulocytic recuitment as compared to underdeveloped neonatal Tg&#x2b; lungs. Additionally, O<sub>3</sub> exposure worsened the muco-inflammatory features of neonatal <italic>Scnn1b</italic>-Tg&#x2b;, i.e., granulocytic (neutrophilic and eosinophilic) recruitment, perivascular and peribronchiolar inflammation, alveolar space enlargement, septal thickening/consolidation, and mucus obstruction (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). However, in this current study, while granulocytic recruitment, perivascular and peribronchiolar inflammation, alveolar space enlargement, septal thickening/consolidation were present in O<sub>3</sub>-exposed Tg&#x2b; mice, mucus obstruction and production of major gel-forming mucins, i.e., MUC5B and MUC5AC were not different between FA-exposed and O<sub>3</sub>-exposed Tg&#x2b; mice.</p>
<p>It was previously demonstrated that the lungs of Tg&#x2b; mice and O<sub>3</sub>-exposed mice share key immunopathological features (<xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>; <xref ref-type="bibr" rid="B8">Choudhary et al., 2021a</xref>; <xref ref-type="bibr" rid="B9">Choudhary et al., 2021b</xref>; <xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). For instance: 1) airway inflammation, as evidenced by the increased granulocytic recruitment; 2) increased number of macrophages; 3) increased levels of inflammatory mediators; and 4) enhanced muco-inflammatory responses. Alveolar macrophages (AMs), sentinel cells in the airspace at homeostasis, patrol the epithelial surfaces of the pulmonary airway and alveolar spaces and face the continued onslaught from inhaled environmental insults (<xref ref-type="bibr" rid="B27">Hussell and Bell, 2014</xref>). Thus, we speculated that AMs play a critical role in regulating O<sub>3</sub>-induced lung injury. An earlier study in mice exposed to O<sub>3</sub> showed that macrophages expressed increased levels of MCP-1, a potent neutrophil and macrophage chemoattractant (<xref ref-type="bibr" rid="B62">Zhao et al., 1998</xref>), consistent with the observed increased in the levels of MCP-1 in the BALF of O<sub>3</sub>-exposed Tg&#x2b; mice as compared to FA-exposed Tg&#x2b; mice. Additionally, mucus obstruction is a consistent feature of <italic>Scnn1b</italic>-Tg&#x2b; lung disease (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>; <xref ref-type="bibr" rid="B33">Lewis et al., 2020a</xref>; <xref ref-type="bibr" rid="B36">2020b</xref>; <xref ref-type="bibr" rid="B35">2017</xref>; <xref ref-type="bibr" rid="B40">Mall et al., 2004</xref>; <xref ref-type="bibr" rid="B43">Mao et al., 2022</xref>). Gel-forming mucins, i.e., MUC5B and MUC5AC were previously found to be enriched in the exosomes of O<sub>3</sub>-exposed C57BL/6J mice (<xref ref-type="bibr" rid="B9">Choudhary et al., 2021b</xref>). Consistent with these reports, a study using neonatal <italic>Scnn1b</italic>-Tg&#x2b; mouse model demonstrated the marked increase in mucus obstruction levels, accompanied by the increased levels of MUC5B and MUC5AC in O<sub>3</sub>-exposed Tg&#x2b; mice (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). However, in current study, while AB-PAS data showed that the levels of mucus obstruction trended higher in O<sub>3</sub>-exposed Tg&#x2b; mice, the levels of MUC5B and MUC5AC were not significantly different between O<sub>3</sub>-exposed and FA-exposed Tg&#x2b; mice. While these findings suggest similarities in muco-inflammatory responses between Tg&#x2b; and O<sub>3</sub> exposed mice, the severity of the injury and the effect of lung development stage reveal distinct features.</p>
<p>Most of the assayed cytokines, e.g., C-X-C motif chemokine 10 (CXCL10/IP-10), macrophage inflammatory protein 1-beta (MIP-1&#x3b2;/CCL4), interleukin-6 (IL-6), keratinocyte chemoattractant (KC/CXCL1), granulocyte-colony stimulating factor (G-CSF), macrophage inflammatory protein 2 (MIP-2/CXCL2), and interleukin-5 (IL-5) levels, showed consistent trend with our previous report (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>). Interestingly, interleukin-10 (IL-10) showed opposite trend, i.e., the BALF levels of IL-10 were significantly lower in O<sub>3</sub>-exposed Tg&#x2b; mice. IL-10 is an anti-inflammatory mediator, mainly produced by T regulatory cells (Tregs) (<xref ref-type="bibr" rid="B17">Fiorentino et al., 1991</xref>), and IL-10 deficiency results in exaggerated inflammation following O<sub>3</sub>-induced lung injury (<xref ref-type="bibr" rid="B4">Backus et al., 2010</xref>). Whether the reduced levels of IL-10 cause exaggerated inflammation in O<sub>3</sub>-exposed Tg&#x2b; mice require further investigation.</p>
<p>Our data suggest that exposure to O<sub>3</sub> results in increased total protein contents, total dsDNA contents, and phagocytosed lipids in Tg&#x2b; mice (<xref ref-type="fig" rid="F6">Figure 6</xref>). Additionally, O<sub>3</sub> enhances immune cell recruitment in Tg&#x2b; mice (<xref ref-type="fig" rid="F6">Figure 6</xref>). Furthermore, O<sub>3</sub> exacerbates inflammation, enhances alveolar space enlargement and tissue consolidation, but not lymphoid follicles formation in the lungs of Tg&#x2b; mice (<xref ref-type="fig" rid="F6">Figure 6</xref>). Interestingly, however, as opposed to the previous report in O<sub>3</sub>-exposed neonatal Tg&#x2b; mice (<xref ref-type="bibr" rid="B10">Choudhary et al., 2021c</xref>), where the hallmark features of Tg&#x2b; airway disease, i.e., mucus obstruction and expression of major gel-forming mucins (MUC5B and MUC5AC) were found exacerbated by O<sub>3</sub> exposure, the FA- and O<sub>3</sub>-exposed Tg&#x2b; in this study exhibited comparable responses. Collectively, this study demonstrates that O<sub>3</sub> exacerbates key features of muco-inflammatory lung diseases, with responses to O<sub>3</sub> exposure potentially resulting in different outcomes between young individuals, whose lungs are still developing, and adults with matured lungs.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Diagrammatic summary of the ozone-induced alterations in muco-inflammatory responses in Tg&#x2b; mice.</p>
</caption>
<graphic xlink:href="ftox-07-1540468-g006.tif"/>
</fig>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The animal study was approved by the Institutional Animal Care and Use Committee (IACUC) of Louisiana State University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>TV: Data Curation, Investigation, Formal Analysis, Methodology, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review and editing. SP: Formal Analysis, Investigation, Methodology, Writing &#x2013; original draft, Writing &#x2013; review and editing. YS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by NIH grants (NIEHS Grant &#x23;R01ES030125, NIEHS Grant &#x23;R01ES035439, and NIEHS Grant &#x23;R21ES034509).</p>
</sec>
<ack>
<p>We thank Sherry Ring (Louisiana State University) for histological tissue processing. We thank Thaya Stoufflet (Louisiana State University) for assistance with multiple cytokine assays. We thank Camille Here (University of North Carolina at Chapel Hill) for providing MUC5B and MUC5AC antibodies.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/ftox.2025.1540468/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/ftox.2025.1540468/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S1</label>
<caption>
<p>Ozone alters the level of inflammatory mediators in the airspaces of WT and Scnn<italic>1b-</italic>Tg&#x2b; mice. Cytokine levels (pg/ml; picogram per milliliter) of <bold>(A)</bold> granulocyte-colony stimulating factor (G-CSF), <bold>(B)</bold> macrophage inflammatory protein 2 (MIP-2/CXCL2), <bold>(C)</bold> keratinocyte chemoattractant (KC/ CXCL1), <bold>(D)</bold> macrophage inflammatory protein 1-alpha (MIP-1&#x3b1;/CCL3), <bold>(E)</bold> macrophage inflammatory protein 1-beta (MIP-1&#x3b2;/CCL4), <bold>(F)</bold> interleukin-1 alpha (IL-1&#x3b1;), <bold>(G)</bold> interleukin-6 (IL-6), <bold>(H)</bold> C-X-C motif chemokine 10 (CXCL10/IP-10), <bold>(I)</bold> tumor necrosis factor alpha (TNF-&#x3b1;), <bold>(J)</bold> interleukin-17 (IL-17), <bold>(K)</bold> interleukin-9 (IL-9), <bold>(L)</bold> interleukin-10 (IL-10) in the BALF from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison post hoc test.</p>
</caption>
</supplementary-material>
<supplementary-material>
<label>SUPPLEMENTARY FIGURE S2</label>
<caption>
<p>Ozone increases RETNLA expression in the airspaces of WT and <italic>Scnn1b-</italic>Tg&#x2b; mice. <bold>(A)</bold> Representative photomicrographs of RETNLA-stained lung sections from FA-exposed WT (blue dotted border), O<sub>3</sub>-exposed WT (red dotted border), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid border), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid border) mice. Red arrows depict alveolar macrophages positively stained for RETNLA. All photomicrographs were taken at same magnification. <bold>(B)</bold> Quantification of RETNLA-stained cells per unit area analyzed in tissue sections from FA-exposed WT (blue open bar), O<sub>3</sub>-exposed WT (red open bar), FA-exposed <italic>Scnn1b</italic>-Tg&#x2b; (blue solid bar), and O<sub>3</sub>-exposed <italic>Scnn1b</italic>-Tg&#x2b; (red solid bar) mice. Error bars represent standard error of the mean (SEM), &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison post hoc test.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image2.jpeg" id="SM1" mimetype="application/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.jpg" id="SM2" mimetype="application/jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Braithwaite</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hills</surname>
<given-names>C. C.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Trace organic compounds in landfill gas at seven U.K. Waste disposal sites</article-title>. <source>Environ. Sci. Technol.</source> <volume>31</volume>, <fpage>1054</fpage>&#x2013;<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.1021/es9605634</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awang</surname>
<given-names>N. R.</given-names>
</name>
<name>
<surname>Elbayoumi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramli</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Yahaya</surname>
<given-names>A. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Diurnal variations of ground-level ozone in three port cities in Malaysia</article-title>. <source>Air Qual. Atmos. Health</source> <volume>9</volume>, <fpage>25</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1007/s11869-015-0334-7</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babusyte</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stravinskaite</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jeroch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>L&#xf6;tvall</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sakalauskas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sitkauskiene</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD</article-title>. <source>Respir. Res.</source> <volume>8</volume>, <fpage>81</fpage>. <pub-id pub-id-type="doi">10.1186/1465-9921-8-81</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backus</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Howden</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fostel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Marzec</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Protective role of interleukin-10 in ozone-induced pulmonary inflammation</article-title>. <source>Environ. Health Perspect.</source> <volume>118</volume>, <fpage>1721</fpage>&#x2013;<lpage>1727</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1002182</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartman</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Matveyenko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>Y. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>It&#x2019;s about time: clocks in the developing lung</article-title>. <source>J. Clin. Investigation</source> <volume>130</volume>, <fpage>39</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1172/JCI130143</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bascom</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dockery</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Frampton</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>1996</year>). <article-title>Health effects of outdoor air pollution. Committee of the environmental and occupational health assembly of the American thoracic society</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>153</volume>, <fpage>3</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.153.1.8542133</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Arjomandi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Balmes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tager</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults</article-title>. <source>Environ. Health Perspect.</source> <volume>115</volume>, <fpage>1732</fpage>&#x2013;<lpage>1737</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.10294</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhary</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Compartment-specific transcriptomics of ozone-exposed murine lungs reveals sex- and cell type-associated perturbations relevant to mucoinflammatory lung diseases</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>320</volume>, <fpage>L99</fpage>&#x2013;<lpage>L125</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00381.2020</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhary</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kesimer</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Vesicular and extravesicular protein analyses from the airspaces of ozone-exposed mice revealed signatures associated with mucoinflammatory lung disease</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>23203</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-02256-5</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhary</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021c</year>). <article-title>Postnatal ozone exposure disrupts alveolar development, exaggerates mucoinflammatory responses, and suppresses bacterial clearance in developing scnn1b-tg&#x2b; mice lungs</article-title>. <source>J. Immunol.</source> <volume>207</volume>, <fpage>1165</fpage>&#x2013;<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.2001286</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Brauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burnett</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Frostad</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Estep</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015</article-title>. <source>Lancet</source> <volume>389</volume>, <fpage>1907</fpage>&#x2013;<lpage>1918</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)30505-6</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Currie</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>van Schaik</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Enhorning</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Ozone affects breathing and pulmonary surfactant function in mice</article-title>. <source>Toxicology</source> <volume>125</volume>, <fpage>21</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/s0300-483x(97)00158-3</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dahl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Arredouani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soininen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tryggvason</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kleeberger</surname>
<given-names>S. R.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II</article-title>. <source>J. Clin. Invest.</source> <volume>117</volume>, <fpage>757</fpage>&#x2013;<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1172/JCI29968</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engle</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Monk</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Jania</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice</article-title>. <source>PLoS ONE</source> <volume>14</volume>, <fpage>e0212866</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0212866</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farhat</surname>
<given-names>S. C. L.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Silva-Filho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>Farhat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis</article-title>. <source>Chest</source> <volume>144</volume>, <fpage>1186</fpage>&#x2013;<lpage>1192</lpage>. <pub-id pub-id-type="doi">10.1378/chest.12-2414</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finlay</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>O&#x2019;Driscoll</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>D&#x2019;Arcy</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Masterson</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>M. X.</given-names>
</name>
<etal/>
</person-group> (<year>1997</year>). <article-title>Matrix metalloproteinase expression and production by alveolar macrophages in emphysema</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>156</volume>, <fpage>240</fpage>&#x2013;<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.156.1.9612018</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fiorentino</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Zlotnik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mosmann</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>O&#x2019;Garra</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>IL-10 inhibits cytokine production by activated macrophages</article-title>. <source>J Immunol</source>. <volume>147</volume>, (<issue>11</issue>) <fpage>3815</fpage>&#x2013;<lpage>3822</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.147.11.3815</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritzsching</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hagner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Christochowitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van Bodegom</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile mice</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>140</volume>, <fpage>190</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.09.045</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geiser</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quaile</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wenk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wigge</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Eigeldinger-Berthou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hirn</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease</article-title>. <source>Part Fibre Toxicol.</source> <volume>10</volume>, <fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/1743-8977-10-19</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerrity</surname>
<given-names>T. R.</given-names>
</name>
<name>
<surname>Biscardi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Strong</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garlington</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Bronchoscopic determination of ozone uptake in humans</article-title>. <source>J. Appl. Physiology</source> <volume>79</volume>, <fpage>852</fpage>&#x2013;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1995.79.3.852</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstein</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>The pulmonary and extrapulmonary effects of ozone</article-title>. <source>Ciba Found Symp</source>, <publisher-name>London: Novartis Foundation Symposia</publisher-name>. <volume>6-8</volume>;(65), <fpage>295</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1002/9780470715413.ch17</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goss</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Newsom</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Schildcrout</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Sheppard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>169</volume>, <fpage>816</fpage>&#x2013;<lpage>821</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200306-779OC</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grasemann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ratjen</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Cystic fibrosis</article-title>. <source>N. Engl. J. Med.</source> <volume>389</volume>, <fpage>1693</fpage>&#x2013;<lpage>1707</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra2216474</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hautamaki</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Senior</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>S. D.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice</article-title>. <source>Science</source> <volume>277</volume>, <fpage>2002</fpage>&#x2013;<lpage>2004</lpage>. <pub-id pub-id-type="doi">10.1126/science.277.5334.2002</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawkins</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Golledge</surname>
<given-names>H. D. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The 9 to 5 Rodent &#x2212; Time for Change? Scientific and animal welfare implications of circadian and light effects on laboratory mice and rats</article-title>. <source>J. Neurosci. Methods, Meas. Behav.</source> <volume>300</volume>, <fpage>20</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2017.05.014</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hendrix</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Kheradmand</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2017</year>). &#x201c;<article-title>The role of matrix metalloproteinases in development, repair, and destruction of the lungs</article-title>,&#x201d; in <source>Progress in molecular biology and translational science</source>. <publisher-loc>New York, NY, United States</publisher-loc>, <publisher-name>Elsevier</publisher-name>, <fpage>1</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2017.04.004</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Alveolar macrophages: plasticity in a tissue-specific context</article-title>. <source>Nat. Rev. Immunol.</source> <volume>14</volume>, <fpage>81</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/nri3600</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobsen</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Ochkur</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>LeSuer</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Protheroe</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Lung pathologies in a chronic inflammation mouse model are independent of eosinophil degranulation</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>195</volume>, <fpage>1321</fpage>&#x2013;<lpage>1332</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201606-1129OC</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joyner</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Coverstone</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Abode</surname>
<given-names>K. A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries</article-title>. <source>J. Burn Care Res.</source> <volume>34</volume>, <fpage>326</fpage>&#x2013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1097/BCR.0b013e31825d5126</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khatri</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Holguin</surname>
<given-names>F. C.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Mannino</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Erzurum</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Teague</surname>
<given-names>W. G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma</article-title>. <source>J. Asthma</source> <volume>46</volume>, <fpage>777</fpage>&#x2013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1080/02770900902779284</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Livraghi-Butrico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier</article-title>. <source>Thorax</source> <volume>77</volume>, <fpage>812</fpage>&#x2013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2020-215185</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirchner</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Wagener</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>T. Z.</given-names>
</name>
<name>
<surname>Copenhaver</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Accurso</surname>
<given-names>F. J.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>154</volume>, <fpage>1426</fpage>&#x2013;<lpage>1429</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.154.5.8912759</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Paudel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>The innate lymphoid system is a critical player in the manifestation of mucoinflammatory airway disease in mice</article-title>. <source>J. Immunol.</source> <volume>205</volume>, <fpage>1695</fpage>&#x2013;<lpage>1708</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.2000530</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Immunopathology of airway surface liquid dehydration disease</article-title>. <source>J. Immunol. Res.</source> <volume>2019</volume>, <fpage>2180409</fpage>. <pub-id pub-id-type="doi">10.1155/2019/2180409</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>No&#xeb;l</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Langohr</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Early postnatal secondhand smoke exposure disrupts bacterial clearance and abolishes immune responses in muco-obstructive lung disease</article-title>. <source>J. Immunol.</source> <volume>199</volume>, <fpage>1170</fpage>&#x2013;<lpage>1183</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700144</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kidder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bathula</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ehre</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020b</year>). <article-title>Ablation of IL-33 suppresses Th2 responses but is accompanied by sustained mucus obstruction in the Scnn1b transgenic mouse model</article-title>. <source>J. Immunol.</source> <volume>204</volume>, <fpage>1650</fpage>&#x2013;<lpage>1660</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1900234</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>S.-A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Chronic exposure to ambient ozone and asthma hospital admissions among children</article-title>. <source>Environ. Health Perspect.</source> <volume>116</volume>, <fpage>1725</fpage>&#x2013;<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.11184</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livraghi-Butrico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grubb</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Volmer</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>C. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease</article-title>. <source>Mucosal Immunol.</source> <volume>10</volume>, <fpage>395</fpage>&#x2013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2016.63</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malig</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Broadwin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R. S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>A time-stratified case-crossover study of ambient ozone exposure and emergency department visits for specific respiratory diagnoses in California (2005&#x2013;2008)</article-title>. <source>Environ. Health Perspect.</source> <volume>124</volume>, <fpage>745</fpage>&#x2013;<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1409495</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mall</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies</article-title>. <source>ERJ Open Research</source>. <volume>56</volume> (<issue>6</issue>), <fpage>2000946</fpage>. <pub-id pub-id-type="doi">10.1183/13993003.00946-2020</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mall</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grubb</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Harkema</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>O&#x2019;Neal</surname>
<given-names>W. K.</given-names>
</name>
<name>
<surname>Boucher</surname>
<given-names>R. C.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Increased airway epithelial Na&#x2b; absorption produces cystic fibrosis-like lung disease in mice</article-title>. <source>Nat. Med.</source> <volume>10</volume>, <fpage>487</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1038/nm1028</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mall</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Button</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Johannesson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Livraghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume>, <fpage>26945</fpage>&#x2013;<lpage>26955</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.151803</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mall</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Harkema</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Trojanek</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Treis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Livraghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Development of chronic bronchitis and emphysema in beta-epithelial Na&#x2b; channel-overexpressing mice</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>177</volume>, <fpage>730</fpage>&#x2013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200708-1233OC</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Airway epithelial cell-specific deletion of HMGB1 exaggerates inflammatory responses in mice with muco-obstructive airway disease</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>944772</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.944772</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>De Gouw</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Gilman</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Jathar</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Akherati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cappa</surname>
<given-names>C. D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Volatile chemical products emerging as largest petrochemical source of urban organic emissions</article-title>. <source>Science</source> <volume>359</volume>, <fpage>760</fpage>&#x2013;<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaq0524</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehlman</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Borek</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Toxicity and biochemical mechanisms of ozone</article-title>. <source>Environ. Res.</source> <volume>42</volume>, <fpage>36</fpage>&#x2013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/s0013-9351(87)80005-1</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michaudel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mackowiak</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maillet</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fauconnier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Akdis</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Sokolowska</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Ozone exposure induces respiratory barrier biphasic injury and inflammation controlled by IL-33</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>142</volume>, <fpage>942</fpage>&#x2013;<lpage>958</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2017.11.044</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>N&#xe9;nan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lagente</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Planquois</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Hitier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Berna</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bertrand</surname>
<given-names>C. P.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Metalloelastase (MMP-12) induced inflammatory response in mice airways: effects of dexamethasone, rolipram and marimastat</article-title>. <source>Eur. J. Pharmacol.</source> <volume>559</volume>, <fpage>75</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2006.11.070</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patial</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Lung macrophages: current understanding of their roles in Ozone-induced lung diseases</article-title>. <source>Crit. Rev. Toxicol.</source> <volume>50</volume>, <fpage>310</fpage>&#x2013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1080/10408444.2020.1762537</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rackley</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Stripp</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Building and maintaining the epithelium of the lung</article-title>. <source>J. Clin. Invest.</source> <volume>122</volume>, <fpage>2724</fpage>&#x2013;<lpage>2730</lpage>. <pub-id pub-id-type="doi">10.1172/JCI60519</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinhart</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>A review of recent studies on the sources of hazardous compounds emitted from solid waste landfills: a U.S. Experience</article-title>. <source>Waste Manag. and Res.</source> <volume>11</volume>, <fpage>257</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1006/wmre.1993.1025</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindelin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Arganda-Carreras</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Frise</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kaynig</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Longair</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pietzsch</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nat. Methods</source> <volume>9</volume>, <fpage>676</fpage>&#x2013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shteinberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haq</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Polineni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cystic fibrosis</article-title>. <source>Lancet</source> <volume>397</volume>, <fpage>2195</fpage>&#x2013;<lpage>2211</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)32542-3</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stokinger</surname>
<given-names>H. E.</given-names>
</name>
</person-group> (<year>1965</year>). <article-title>Ozone toxicology. a review of research and industrial experience: 1954-1964</article-title>. <source>Arch. Environ. Health</source> <volume>10</volume>, <fpage>719</fpage>&#x2013;<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1080/00039896.1965.10664082</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strickland</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Darrow</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flanders</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Sarnat</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Waller</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Short-term associations between ambient air pollutants and pediatric asthma emergency department visits</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>182</volume>, <fpage>307</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200908-1201oc</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strosnider</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Darrow</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Vaidyanathan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Strickland</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Age-Specific associations of ozone and fine particulate matter with respiratory emergency department visits in the United States</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>199</volume>, <fpage>882</fpage>&#x2013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201806-1147OC</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Juan</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Association between ambient air pollution and daily hospital admissions for ischemic stroke: a nationwide time-series analysis</article-title>. <source>PLoS Med.</source> <volume>15</volume>, <fpage>e1002668</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002668</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Triantaphyllopoulos</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pinart</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Adcock</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>300</volume>, <fpage>L691</fpage>&#x2013;<lpage>L700</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00252.2010</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trojanek</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Cobos-Correa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Diemer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kormann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Zhou-Suckow</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>51</volume>, <fpage>709</fpage>&#x2013;<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2013-0407OC</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warner</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Beltran</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Younkin</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Varani</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>K. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The role of metalloelastase in immune complex-induced acute lung injury</article-title>. <source>Am. J. Pathology</source> <volume>158</volume>, <fpage>2139</fpage>&#x2013;<lpage>2144</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64685-8</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Low-level ambient ozone exposure associated with neutrophil extracellular traps and pro-atherothrombotic biomarkers in healthy adults</article-title>. <source>Atherosclerosis</source> <volume>395</volume>, <fpage>117509</fpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2024.117509</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Leikauf</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Chemokine regulation of ozone-induced neutrophil and monocyte inflammation</article-title>. <source>Am. J. Physiol.</source> <volume>274</volume>, <fpage>L39</fpage>&#x2013;<lpage>L46</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.1998.274.1.L39</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Duerr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johannesson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Treis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Harm</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease</article-title>. <source>J. Cyst. Fibros.</source> <volume>10</volume> (<issue>Suppl. 2</issue>), <fpage>S172</fpage>&#x2013;<lpage>S182</lpage>. <pub-id pub-id-type="doi">10.1016/S1569-1993(11)60021-0</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>